298. 遺伝性膵炎 Hereditary pancreatitis Clinical trials / Disease details
臨床試験数 : 95 / 薬物数 : 148 - (DrugBank : 51) / 標的遺伝子数 : 53 - 標的パスウェイ数 : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2013-003357-17-DK (EUCTR) | 01/11/2013 | 04/11/2013 | The Ketamine - a novel approach to treating painful chronic pancreatitis. | RESET TrialA randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of S-ketamine for pain treatment in chronic pancreatitis (RESET trial) - RESET Trial | Chronic Pancreatitis MedDRA version: 17.1;Level: LLT;Classification code 10009093;Term: Chronic pancreatitis;System Organ Class: 100000004856 MedDRA version: 17.1;Level: HLT;Classification code 10033646;Term: Acute and chronic pancreatitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] | Trade Name: S-Ketamin Product Name: S-ketamin Trade Name: Midazolam Product Name: Midazolam | Prof. Asbjørn Mohr Drewes | NULL | Not Recruiting | Female: yes Male: yes | 60 | Phase 4 | Denmark |